| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |